Links from this page to related variants, conditions, drugs and topics are not included for automated readers. Those connections are the Gene Knowledge Graph and are licensed as data: https://www.mygenelog.com/license

Standard

Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage

ZGPAT · rs62217799

Strength of the evidence

1 / 4

Its strongest genetic-study result is p = 10−17, with 8 associations in the GWAS Catalog.

How this is scored

4: ClinVar disease-causing, reviewed by an expert panel or a guideline (3–4 stars). 3: ClinVar, several labs agreeing (2 stars), or a genetic study at p ≤ 10−50. 2: ClinVar from one lab (1 star), or p ≤ 10−20. 1: ClinVar submitted without criteria (0 stars), or genome-wide significance (p ≤ 5×10−8). The higher of the two counts. It says how solid the evidence is, not whether it matters for a particular person.

What the study found

Who was studied 434,646 British ancestry individuals, 8,796 British Central/South Asian individuals, 6,573 British African individuals.

The effect Each copy of the T allele shifted the measure 0.01 % lower (95% confidence interval 0.01-0.01); p = 3 × 10−11.

Where it sits Chromosome 20, band 20q13.33 — in an intron of ZGPAT.

How common each version is

GT
Korean KRGDB
G 62.7% · T 37.3%
Korean Korea4K
G 63.7% · T 36.3%
Japanese ToMMo
G 58.0% · T 42.0%
World gnomAD
G 25.6% · T 74.4%
World 1000 Genomes
G 29.3% · T 70.7%
World TOPMed
G 25.4% · T 74.6%

By ancestry gnomAD

East Asian
G 58.7% · T 41.3%
European (non-Finnish)
G 31.5% · T 68.5%
African / African American
G 9.8% · T 90.2%
South Asian
G 29.9% · T 70.0%
Admixed American (Latino)
G 28.0% · T 72.0%
Middle Eastern
G 26.5% · T 73.5%
Finnish
G 26.7% · T 73.3%
Ashkenazi Jewish
G 28.6% · T 71.4%

The share of all copies of this position that are each version. Source: the population studies published in dbSNP (US NCBI); each row names its study. The ancestry rows are gnomAD's own groups (via Ensembl), as the survey defines them, not races.

What each result means

G/G No copy of the version the research linked to Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage. This is the starting point the study compared everyone against.
G/T One copy of the version the research linked to Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage. That is a smaller link than two copies.
T/T Two copies of the version the research linked to Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage. That is the strongest link of the three results. A link in a study is not a diagnosis.
Source

Quoting this page

Licensed CC BY-NC 4.0: free to read, share and adapt for non-commercial use, naming MyGeneLog™ and linking the exact page. Commercial use, including training or serving a commercial AI system, needs a licence — https://www.mygenelog.com/license

Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage (rs62217799). MyGeneLog™. https://www.mygenelog.com/variants/rs62217799

← See all variants